SG10201908922UA - Identification of health status in the elderly using immunological biomarkers - Google Patents

Identification of health status in the elderly using immunological biomarkers

Info

Publication number
SG10201908922UA
SG10201908922UA SG10201908922UA SG10201908922UA SG10201908922UA SG 10201908922U A SG10201908922U A SG 10201908922UA SG 10201908922U A SG10201908922U A SG 10201908922UA SG 10201908922U A SG10201908922U A SG 10201908922UA SG 10201908922U A SG10201908922U A SG 10201908922UA
Authority
SG
Singapore
Prior art keywords
elderly
identification
health status
immunological biomarkers
biomarkers
Prior art date
Application number
SG10201908922UA
Other languages
English (en)
Inventor
Jonathan Michael Blackburn
Arif Anwar
Nurul H Rutt
Anis Larbi
Olivier Nicolas Felix Cexus
Bernett Lee
Jesus Felix Batya Valenzuela
Christopher Monterola
Victor Tong
Original Assignee
Sengenics Corp Pte Ltd
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sengenics Corp Pte Ltd, Agency Science Tech & Res filed Critical Sengenics Corp Pte Ltd
Priority to SG10201908922UA priority Critical patent/SG10201908922UA/en
Priority to AU2020356141A priority patent/AU2020356141A1/en
Priority to US17/763,572 priority patent/US20230228741A1/en
Priority to CA3152465A priority patent/CA3152465A1/fr
Priority to PCT/SG2020/050540 priority patent/WO2021061048A1/fr
Priority to JP2022519515A priority patent/JP2022550377A/ja
Priority to KR1020227012393A priority patent/KR20220069032A/ko
Priority to CN202080080356.4A priority patent/CN114761808A/zh
Priority to EP20868311.0A priority patent/EP4034884A4/fr
Publication of SG10201908922UA publication Critical patent/SG10201908922UA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/9121Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/99Isomerases (5.)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG10201908922UA 2019-09-25 2019-09-25 Identification of health status in the elderly using immunological biomarkers SG10201908922UA (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SG10201908922UA SG10201908922UA (en) 2019-09-25 2019-09-25 Identification of health status in the elderly using immunological biomarkers
AU2020356141A AU2020356141A1 (en) 2019-09-25 2020-09-23 Identification of health status in the elderly using immunological biomarkers
US17/763,572 US20230228741A1 (en) 2019-09-25 2020-09-23 Identification of health status in the elderly using immunological biomarkers
CA3152465A CA3152465A1 (fr) 2019-09-25 2020-09-23 Identification de l'etat de sante de sujets ages au moyen de biomarqueurs immunologiques
PCT/SG2020/050540 WO2021061048A1 (fr) 2019-09-25 2020-09-23 Identification de l'état de santé de sujets âgés au moyen de biomarqueurs immunologiques
JP2022519515A JP2022550377A (ja) 2019-09-25 2020-09-23 免疫学的バイオマーカーを使用する高齢者における健康状態の特定
KR1020227012393A KR20220069032A (ko) 2019-09-25 2020-09-23 면역학적 바이오마커를 이용한 노인의 건강 상태 확인
CN202080080356.4A CN114761808A (zh) 2019-09-25 2020-09-23 使用免疫生物标志物对老年人的健康状况进行鉴定的方法
EP20868311.0A EP4034884A4 (fr) 2019-09-25 2020-09-23 Identification de l'état de santé de sujets âgés au moyen de biomarqueurs immunologiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201908922UA SG10201908922UA (en) 2019-09-25 2019-09-25 Identification of health status in the elderly using immunological biomarkers

Publications (1)

Publication Number Publication Date
SG10201908922UA true SG10201908922UA (en) 2021-04-29

Family

ID=75169155

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201908922UA SG10201908922UA (en) 2019-09-25 2019-09-25 Identification of health status in the elderly using immunological biomarkers

Country Status (9)

Country Link
US (1) US20230228741A1 (fr)
EP (1) EP4034884A4 (fr)
JP (1) JP2022550377A (fr)
KR (1) KR20220069032A (fr)
CN (1) CN114761808A (fr)
AU (1) AU2020356141A1 (fr)
CA (1) CA3152465A1 (fr)
SG (1) SG10201908922UA (fr)
WO (1) WO2021061048A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2799309A1 (fr) * 2010-05-13 2011-11-17 University Of Medicine And Dentistry Of New Jersey Profils d'auto-anticorps diagnostiques pour detecter et diagnostiquer des maladies neurodegeneratives

Also Published As

Publication number Publication date
JP2022550377A (ja) 2022-12-01
AU2020356141A1 (en) 2022-04-21
CN114761808A (zh) 2022-07-15
EP4034884A1 (fr) 2022-08-03
EP4034884A4 (fr) 2023-12-06
CA3152465A1 (fr) 2021-04-01
US20230228741A1 (en) 2023-07-20
WO2021061048A1 (fr) 2021-04-01
KR20220069032A (ko) 2022-05-26

Similar Documents

Publication Publication Date Title
HK1247244A1 (zh) 新型人血清白蛋白突變體
ZA201802059B (en) Assay for the diagnosis of dermatophytosis
IL266857A (en) You will notice antibodies
GB201807409D0 (en) Assay
LT3364193T (lt) Patobulintas tyrimas, skirtas alergijos žemės riešutams diagnozavimui
CA184853S (en) Cleaning pad
IL283491A (en) Device for flow tests
IL281906A (en) A kit for examining biological contamination on a surface
GB201812561D0 (en) Biomarkers and uses thereof
GB201819187D0 (en) Assay
IL283881A (en) Anti-il-17a antibody and its use
IL255789A (en) srm/mrm assay for repressor of cyclin-dependent protein kinase 2a (p16)
IL274477A (en) Biomarker assays for use in autism surveillance
GB2579810B (en) Assay Analysis
GB201820863D0 (en) Screening assay
SG10201908922UA (en) Identification of health status in the elderly using immunological biomarkers
GB201806168D0 (en) Surface Analysis
GB201700954D0 (en) Zoned surface roughness
WO2016100549A3 (fr) Céramides à utiliser pour évaluer un risque de maladie cardiovasculaire
EP4076343C0 (fr) Sérum à base de rétinol
GB201905090D0 (en) Assay device
CA185413S (en) Cleaning pad
GB201814532D0 (en) in vitro dianostic assay methods
ITUB20152102A1 (it) Bevanda energetica e procedimento per la sua preparazione ed il suo condizionamento
GB201815278D0 (en) Assay